Ranajit Pal

3.9k total citations
85 papers, 2.6k citations indexed

About

Ranajit Pal is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Ranajit Pal has authored 85 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Virology, 41 papers in Immunology and 28 papers in Epidemiology. Recurrent topics in Ranajit Pal's work include HIV Research and Treatment (66 papers), Immune Cell Function and Interaction (21 papers) and HIV/AIDS drug development and treatment (19 papers). Ranajit Pal is often cited by papers focused on HIV Research and Treatment (66 papers), Immune Cell Function and Interaction (21 papers) and HIV/AIDS drug development and treatment (19 papers). Ranajit Pal collaborates with scholars based in United States, Italy and India. Ranajit Pal's co-authors include Robert R. Wagner, Yechezkel Barenholz, David C. Montefiori, Phillip D. Markham, V. S. Kalyanaraman, M. G. Sarngadharan, Anthony L. DeVico, George Hoke, Shixia Wang and Shan Lu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Ranajit Pal

85 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ranajit Pal United States	33	1.7k	1.2k	888	698	680	85	2.6k
Shiu-Lok Hu United States	29	2.1k 1.2×	1.5k 1.2×	896 1.0×	889 1.3×	1.0k 1.5×	71	3.2k
Clotilde Thiriart Belgium	18	1.2k 0.7×	660 0.6×	645 0.7×	567 0.8×	556 0.8×	23	2.0k
Richard B. Ciccarelli United States	25	735 0.4×	1.5k 1.3×	1.2k 1.3×	452 0.6×	708 1.0×	43	2.8k
Lucinda A. Ivanoff United States	7	1.9k 1.2×	809 0.7×	828 0.9×	1.2k 1.7×	526 0.8×	7	2.6k
Shuyi Wang United States	17	2.1k 1.3×	1.2k 1.0×	888 1.0×	1.1k 1.5×	760 1.1×	35	3.3k
Yu Feng United States	23	2.9k 1.7×	2.4k 2.0×	927 1.0×	1.0k 1.5×	543 0.8×	38	4.2k
Randal A. Byrn United States	27	2.3k 1.4×	1.5k 1.3×	1.1k 1.2×	1.4k 2.0×	944 1.4×	49	4.0k
Jean‐Claude Gluckman France	17	2.1k 1.3×	1.4k 1.2×	596 0.7×	1.0k 1.5×	646 0.9×	37	2.9k
J G Sodroski United States	20	2.1k 1.3×	1.1k 1.0×	848 1.0×	1.1k 1.6×	626 0.9×	23	2.9k
Douglas W. Grosenbach United States	30	1.3k 0.8×	1.2k 1.0×	1.2k 1.3×	237 0.3×	1.0k 1.5×	43	2.8k

Countries citing papers authored by Ranajit Pal

Since Specialization

Citations

This map shows the geographic impact of Ranajit Pal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranajit Pal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranajit Pal more than expected).

Fields of papers citing papers by Ranajit Pal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranajit Pal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranajit Pal. The network helps show where Ranajit Pal may publish in the future.

Co-authorship network of co-authors of Ranajit Pal

This figure shows the co-authorship network connecting the top 25 collaborators of Ranajit Pal. A scholar is included among the top collaborators of Ranajit Pal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranajit Pal. Ranajit Pal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pal, Ranajit, et al.. (2024). Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates. Vaccine. 42(5). 1122–1135. 5 indexed citations

Thoene, Jess G., et al.. (2022). In vitro activity of cysteamine against SARS-CoV-2 variants. Molecular Genetics and Metabolism. 137(1-2). 192–200. 8 indexed citations

Pal, Ranajit, Lindsey Galmin, Lara Pereira, et al.. (2012). Virological and molecular characterization of a simian human immunodeficiency virus (SHIV) encoding the envelope and reverse transcriptase genes from HIV-1. Virology. 432(1). 173–183. 8 indexed citations

Patterson, L. Jean, Peng Xiao, Jun Zhao, et al.. (2011). Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge. Virology. 411(1). 87–102. 16 indexed citations

Pise-Masison, Cynthia A., Michael F. Radonovich, John Brady, et al.. (2008). Cellular Gene Expression Profiles in Rhesus Macaques Challenged Mucosally with a Pathogenic R5 Tropic Simian Human Immunodeficiency Virus Isolate. Viral Immunology. 21(4). 411–423. 6 indexed citations

Wang, Shixia, Jeffrey S. Kennedy, Kim West, et al.. (2008). Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers. Vaccine. 26(31). 3947–3957. 84 indexed citations

DeVico, Anthony L., Timothy Fouts, George K. Lewis, et al.. (2007). Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens. Proceedings of the National Academy of Sciences. 104(44). 17477–17482. 65 indexed citations

Malkevitch, Nina, L. Jean Patterson, Yichen Wu, et al.. (2006). Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: Role of SIV-specific CD8+ T cell responses. Virology. 353(1). 83–98. 56 indexed citations

Pal, Ranajit, Shixia Wang, V. S. Kalyanaraman, et al.. (2006). Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype. Virology. 348(2). 341–353. 73 indexed citations

10.

Wang, Shixia, Ranajit Pal, John R. Mascola, et al.. (2006). Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E. Virology. 350(1). 34–47. 86 indexed citations

11.

Cristillo, Anthony D., Shixia Wang, Leilei He, et al.. (2005). Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine. Virology. 346(1). 151–168. 38 indexed citations

12.

Santra, Sampa, Jörn E. Schmitz, Marcelo J. Kuroda, et al.. (2002). Recombinant Canarypox Vaccine-Elicited CTL Specific for Dominant and Subdominant Simian Immunodeficiency Virus Epitopes in Rhesus Monkeys. The Journal of Immunology. 168(4). 1847–1853. 30 indexed citations

13.

DeVico, Anthony L., et al.. (1996). Covalently Crosslinked Complexes of Human Immunodeficiency Virus Type 1 (HIV-1) gp120 and CD4 Receptor Elicit a Neutralizing Immune Response That Includes Antibodies Selective for Primary Virus Isolates. Virology. 218(1). 258–263. 37 indexed citations

14.

Veronese, Fulvia, Rukhsana Rahman, Ranajit Pal, et al.. (1992). Delineation of Immunoreactive, Conserved Regions in the External Glycoprotein of the Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 8(6). 1125–1132. 18 indexed citations

15.

Pal, Ranajit, George Hoke, Renato V. LaRocca, et al.. (1991). Effect of Evans Blue and Trypan Blue on Syncytia Formation and Infectivity of Human Immunodeficiency Virus Type I and Type II In Vitro. AIDS Research and Human Retroviruses. 7(6). 537–543. 12 indexed citations

16.

Pal, Ranajit, et al.. (1991). Brefeldin A Inhibits the Processing and Secretion of Envelope Glycoproteins of Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 7(8). 707–712. 32 indexed citations

17.

Stein, Christian, Ranajit Pal, Anthony L. DeVico, et al.. (1991). Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro. Biochemistry. 30(9). 2439–2444. 69 indexed citations

18.

Pal, Ranajit, Marvin S. Reitz, Erwin Tschachler, et al.. (1990). Myristoylation of gag Proteins of HIV-1 Plays an Important Role in Virus Assembly. AIDS Research and Human Retroviruses. 6(6). 721–730. 94 indexed citations

19.

Pal, Ranajit, V. S. Kalyanaraman, George Hoke, & M. G. Sarngadharan. (1989). Processing and Secretion of Envelope Glycoproteins of Human Immunodeficiency Virus Type 1 in the Presence of Trimming Glucosidase Inhibitor Deoxynojirimycin. Intervirology. 30(1). 27–35. 33 indexed citations

20.

Veronese, Fulvia, Rukhsana Rahman, Vaniambadi S. Kalyanaraman, et al.. (1989). Monoclonal Antibodies to HTLV-III ₄₅₁ gp41: Delineation of an Immunoreactive Conserved Epitope in the Transmembrane Region of Divergent Isolates of HIV-1. AIDS Research and Human Retroviruses. 5(5). 479–486. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact